Caplyta & This Little Light of Mine? Artwork

Druggist For The People

Four score and seven minutes ago (about an hour and a half) your physician brought forth, upon her desk, a new prescription, conceived in best medical practice, and dedicated to the proposition that all generics are created equal. Now we are engaged in a great civilian war, testing whether that medication, or any medication so conceived, and so dedicated, can help us long endure. And maybe we can feel good at the same time. For forty years as a pharmacist, I've been building bridges - from the doctor to those in need of important drug information - you. With respect for the listener, and from the perspective that it is better to apply a recommended course of therapy than it is to comply with an ordered course, the goal here is not to provide specific answers about your drug therapy, but rather to help you generate the questions that will that will empower you in this. Toward that end, there will be weekly podcasts, very often with guests who will be "the people".

All Episodes

Druggist For The People

Caplyta & This Little Light of Mine?

July 07, 2026 • Donald Schoeff

0:00 | 31:25

Send us Fan Mail

Summary:

This podcast addresses the overlap seen in depression and psychosis, and how the second generation antipsychotic meds have expanding FDA-approved indications.

Topics:

· This little light of mine 01:10

· Advertising through you 02:20

· Dopamine 04:00

· Homeostasis-Balance 04:50

· Participate & Communicate 07:00

· Decreased Dopamine 08:15

- Parkinsons

- Restless Leg Syndrome

· Dopamine Receptors

· Increased Dopamine 12:00

- Schizophrenia

· 1st and 2nd Generation Antipsychotics 14:00

· Side Effects 14:40

· Risk-Benefit 15:20

· Extrapyramidal Symptoms 16:15

· Relapse decrease with Caplyta 17:30

· Internet Gaming Disorder 20:00

· Caplyte 25:15

· 5 Steps of Drug Development 28:00

Questions and comments to druggistforthepeople@gmail.com

Donald J. Schoeff, R.Ph.

Host